IP Library Assignment 033630/0592
Patent Assignment
Reel/Frame 033630/0592

Assignment of Assignor's Interest

Recorded: 2014-08-28 Pages: 4
Assignor
BUDERER, MATTHEW J.
Executed: 2014-08-02
Assignee
IMPRIMIS PHARMACEUTICALS, INC.
12626 HIGH BLUFF DRIVE, SUITE 105, SAN DIEGO, CALIFORNIA, 92130
Covered Property (1)
Pharmaceutical Formulations of Xanthine or Xanthine Derivatives, and Their Use
Patent: 9,849,133 →
Application: 14/307,773 →
Publication: US 2015/0017151
Related Assignments (9)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest Jun 16, 2015
From: IMPRIMIS PHARMACEUTICALS, INC.
To: IMMY FUNDING LLC
Reel/Frame 035923/0749 →
Release of Security Interest in Intellectual Property Collateral at Reel/Frame No. 35923/0749 Jul 19, 2017
From: IMMY FUNDING LLC
To: IMPRIMIS PHARMACEUTICALS, INC.
Reel/Frame 043259/0434 →
Intellectual Property Security Agreement Jul 19, 2017
From: IMPRIMIS PHARMACEUTICALS, INC.
To: SWK FUNDING LLC, AS COLLATERAL AGENT
Reel/Frame 043258/0581 →
Assignment of Assignor's Interest Jul 27, 2017
From: IMPRIMIS PHARMACEUTICALS, INC.
To: ETON PHARMACEUTICALS, INC.
Reel/Frame 043120/0957 →
Assignment of Assignor's Interest Jun 7, 2019
From: ETON PHARMACEUTICALS, INC.
To: HARROW IP, LLC
Reel/Frame 049402/0589 →
Release of Security Interest May 7, 2021
From: SWK FUNDING LLC
To: HARROW IP, LLC
Reel/Frame 056174/0332 →
Patent Security Agreement Mar 30, 2023
From: HARROW IP, LLC
To: OAKTREE FUND ADMINISTRATION, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 063205/0708 →
Release of Security Interest Sep 18, 2025
From: OAKTREE FUND ADMINISTRATION, LLC, AS ADMINISTRATIVE AGENT
To: HARROW IP, LLC
Reel/Frame 072299/0911 →
Security Interest Sep 26, 2025
From: HARROW, INC.; HARROW IP, LLC
To: FIFTH THIRD BANK, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 072384/0781 →